Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma

Clinical trial NCT06471738 · RECRUITING

Trial details

NCT number: NCT06471738
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ann Arbor Stage II Follicular Lymphoma Grade 1 Follicular Lymphoma Ann Arbor Stage III Follicular Lymphoma Ann Arbor Stage IV Follicular Lymphoma Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma

Start date: 2024-07-10
Primary completion: 2026-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.